Lyrica 300mg (Pregabalin) Nervigesic, containing the active ingredient Pregabalin, is a prescription-only medication (POM) used to treat neuropathic pain, generalised anxiety disorder, and as an adjunct for partial-onset seizures. This formulation is a generic equivalent of Lyrica 300mg, offering identical efficacy and safety, but at a more accessible price point. Each strip includes 15 capsules, with 1 piece (pcs) representing 1 full strip, and prices start from just £4.00. The product is registered with WEDINOS code W050686, ensuring its verified status.
Because pregabalin targets overactive nerve signals, it delivers both analgesic and anxiolytic benefits. Although originally developed for epilepsy, its effectiveness in treating nerve pain and anxiety has made it a widely prescribed medication across the UK.
Why Choose Lyrica 300mg (Pregabalin) Nervigesic?
Patients prefer Nervigesic 300mg for its reliable pain control, mental calmness, and minimal interaction profile. Since it acts on calcium channels in the central nervous system, it modulates nerve activity without producing the euphoria associated with opioids or the sedation linked to benzodiazepines. As a result, it offers sustained symptom relief while maintaining mental clarity.
Because Lyrica and its generics like Nervigesic are now classified as Schedule 3 Controlled Drugs in the UK, they are dispensed only under prescription. However, online consultations make access faster while remaining fully compliant with MHRA and GMC regulations.
Product Summary – Nervigesic 300mg
-
Active Ingredient: Pregabalin
-
Strength: 300mg per capsule
-
Manufacturer: Signature Pharmaceuticals
-
Brand Name: Nervigesic
-
WEDINOS Code: W050686
-
Form: 15 capsules per blister (1 pcs = 1 strip)
-
Stock: Unlimited
-
Price: From £4.00 per strip
-
Legal Classification: POM, Schedule 3 CD (UK)
Clinical Uses of Lyrica (Pregabalin) 300mg
UK clinicians prescribe pregabalin for a variety of conditions, including:
-
Neuropathic pain (e.g. diabetic nerve pain, post-herpetic neuralgia, spinal cord injury)
-
Generalised Anxiety Disorder (GAD) in adults
-
Partial seizures (adjunct therapy only)
-
Fibromyalgia (off-label)
-
Restless leg syndrome (off-label)
Because this 300mg dose is the maximum recommended daily amount, it is typically used when lower strengths such as 75mg or 150mg prove insufficient. Patients often escalate gradually under clinical supervision.
How to Take Nervigesic 300mg
You should always take Nervigesic exactly as prescribed. Usually, it is taken twice daily—150mg in the morning and 150mg at night—or once daily depending on your doctor’s instructions. Do not chew or crush the capsules. Swallow each with water, with or without food.
To prevent withdrawal or rebound effects, never stop pregabalin suddenly. Taper the dose over at least one week under medical guidance. This approach avoids seizures, anxiety spikes, or insomnia during discontinuation.
Side Effects and Safety Information
Although most patients tolerate pregabalin 300mg well, side effects may still occur. Common side effects include:
-
Dizziness
-
Drowsiness
-
Blurred vision
-
Weight gain
-
Swelling of hands or feet
-
Difficulty concentrating
In rare cases, patients may experience respiratory depression, especially when combined with CNS depressants like opioids, alcohol, or benzodiazepines. Therefore, concurrent use requires close medical monitoring.
Pregabalin can also cause dependence or withdrawal, particularly with long-term use or misuse. For this reason, UK authorities reclassified it as a controlled substance.
Conclusion
Nervigesic 300mg offers an effective, UK-compliant solution for patients living with chronic nerve pain, anxiety, or seizure disorders. It provides strong relief without the sedation or cognitive impairment associated with older medications. Supplied by Signature Pharmaceuticals, each strip contains 15 x 300mg capsules, priced from just £4.00. With WEDINOS code W050686, verified composition, and unlimited stock, Nervigesic remains a trusted, affordable alternative to branded Lyrica in the UK.
